STN: BL 125549 Proper Name: Meningococcal Group B Vaccine Trade Name: TRUMENBA Manufacture: Wyeth Pharmaceuticals, Inc. Indication:
Indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. Trumenba is approved for use in individuals 10 through 25 years of age.
Product Information
Supporting Documents
Related Information
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
